Pay in 4 interest-free payments of $6.34 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
When used as a monotherapymeaning its taken on its own, without being combined with other medicationsits currently being tested in a large phase 3 clinical trial program called RENEW
Research Summary An expanded healing blend adding KPV (Lys-Pro-Val), a potent anti-inflammatory tripeptide derived from -MSH, to the BPC-157/TB-500/GHK-Cu stack
A: DopeRx BPC-157 is intended for parenteral (injection) use and must be administered by a healthcare professional as per prescribed guidelines
Many protocols use them together for enhanced results
Half of participants with obesity who received CagriSema reached a non-obese BMI by the end of treatment
Two peptides, one vial
US$ 24.04
US$ 23.85
US$ 22.53
